# OnCo record pegulicianine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pegulicianine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pegulicianine" ;
  schema:name "Pegulicianine"@en ;
  schema:description "A cavity-imaging dye used during breast lumpectomy to spot leftover tumour before the operation ends, reducing second surgeries."@en ;
  schema:url <https://onco.cc/drugs/pegulicianine/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Pegulicianine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q125693738> ;
  schema:citation <https://doi.org/10.1056/EVIDoa2200333>, <https://clinicaltrials.gov/study/NCT03686215> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "diagnostic" ;
  onco:modality "Protease-activated fluorescent imaging agent" ;
  schema:alternateName "Lumisight" ;
  onco:approval "US 2024: Fluorescence imaging in adults with breast cancer as an adjunct for intraoperative detection of residual cancer after lumpectomy" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/fluorescence-guided-surgery/>, <https://onco.cc/technologies/optical-imaging/> ;
  onco:companies <https://onco.cc/companies/lumicell/> ;
  onco:trials <https://onco.cc/trials/insite/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-smith-nejm-evid/> .